tiprankstipranks
Trending News
More News >
Fusion Pharm Inc (FSPM)
OTHER OTC:FSPM
US Market
Advertisement

Fusion Pharm Inc

Compare
9 Followers

FSPM Stock Chart & Stats

<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)

FSPM FAQ

What was Fusion Pharm Inc’s price range in the past 12 months?
Currently, no data Available
What is Fusion Pharm Inc’s market cap?
Fusion Pharm Inc’s market cap is $1.26K.
    When is Fusion Pharm Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Fusion Pharm Inc’s earnings last quarter?
    Currently, no data Available
    Is Fusion Pharm Inc overvalued?
    According to Wall Street analysts Fusion Pharm Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Fusion Pharm Inc pay dividends?
      Fusion Pharm Inc does not currently pay dividends.
      What is Fusion Pharm Inc’s EPS estimate?
      Fusion Pharm Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Fusion Pharm Inc have?
      Fusion Pharm Inc has 12,591,545 shares outstanding.
        What happened to Fusion Pharm Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Fusion Pharm Inc?
        Currently, no hedge funds are holding shares in FSPM

        Company Description

        Fusion Pharm Inc

        FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. The company also offers its products to businesses, universities, and individuals to cultivate various plants. FusionPharm, Inc. was formerly known as Baby Bee Bright Corp. and changed its name to FusionPharm, Inc. in April 2011. The company was founded in 1998 and is based in Commerce City, Colorado.
        Similar Stocks
        Company
        Price & Change
        Follow
        Biodexa Pharmaceuticals
        Scinai Immunotherapeutics
        Qualigen Therapeutics
        Rein Therapeutics
        Neuphoria Therapeutics

        Ownership Overview

        0.08%99.92%
        Insiders
        Mutual Funds
        0.08% Other Institutional Investors
        99.92% Public Companies and
        Individual Investors

        Options Prices

        Currently, No data available
        ---
        Popular Stocks
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis